E Sullivan

512 total citations
28 papers, 399 citations indexed

About

E Sullivan is a scholar working on Rheumatology, Immunology and Economics and Econometrics. According to data from OpenAlex, E Sullivan has authored 28 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 18 papers in Immunology and 7 papers in Economics and Econometrics. Recurrent topics in E Sullivan's work include Rheumatoid Arthritis Research and Therapies (16 papers), Psoriasis: Treatment and Pathogenesis (13 papers) and Spondyloarthritis Studies and Treatments (11 papers). E Sullivan is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Psoriasis: Treatment and Pathogenesis (13 papers) and Spondyloarthritis Studies and Treatments (11 papers). E Sullivan collaborates with scholars based in United Kingdom, United States and Germany. E Sullivan's co-authors include James Piercy, Sumesh Kachroo, Christopher M. Black, John Waller, James Pike, Yang Zhao, Jenna Roberts, Rieke Alten, Philip G. Conaghan and Vibeke Strand and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

E Sullivan

28 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Sullivan United Kingdom 13 227 193 95 75 50 28 399
F.S. Mennini Italy 9 96 0.4× 62 0.3× 44 0.5× 33 0.4× 34 0.7× 45 343
Taru Hallinen Finland 12 83 0.4× 87 0.5× 102 1.1× 44 0.6× 15 0.3× 29 374
V. Chandran Canada 4 253 1.1× 245 1.3× 17 0.2× 173 2.3× 45 0.9× 4 385
Carole Desthieux France 6 84 0.4× 272 1.4× 18 0.2× 103 1.4× 30 0.6× 9 372
Jerry Syrotuik Canada 7 144 0.6× 69 0.4× 28 0.3× 34 0.5× 13 0.3× 8 313
Herman L. M. Brus Netherlands 9 66 0.3× 318 1.6× 23 0.2× 140 1.9× 42 0.8× 12 456
Brian Bekker Hansen Denmark 13 53 0.2× 95 0.5× 32 0.3× 25 0.3× 13 0.3× 20 441
A. Clarke Canada 9 69 0.3× 183 0.9× 15 0.2× 11 0.1× 71 1.4× 15 332
Marios Kouloumas United Kingdom 6 54 0.2× 208 1.1× 11 0.1× 85 1.1× 10 0.2× 8 311
Valgerður Sigurðardóttir Sweden 9 55 0.2× 131 0.7× 16 0.2× 19 0.3× 10 0.2× 25 367

Countries citing papers authored by E Sullivan

Since Specialization
Citations

This map shows the geographic impact of E Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Sullivan more than expected).

Fields of papers citing papers by E Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Sullivan. The network helps show where E Sullivan may publish in the future.

Co-authorship network of co-authors of E Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of E Sullivan. A scholar is included among the top collaborators of E Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Sullivan. E Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glover, Frank, et al.. (2023). The relationship between klotho, testosterone, and sexual health parameters among US adult men. Journal of Endocrinological Investigation. 47(3). 523–533. 6 indexed citations
2.
Strand, Vibeke, Atul Deodhar, Rieke Alten, et al.. (2021). Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings.. PubMed. 27(8). e446–e455. 12 indexed citations
3.
Sullivan, E, et al.. (2020). Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians. Rheumatology and Therapy. 7(2). 383–400. 15 indexed citations
4.
Conaghan, Philip G., Rieke Alten, Atul Deodhar, et al.. (2020). Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study. RMD Open. 6(2). e001240–e001240. 30 indexed citations
5.
Strand, Vibeke, Atul Deodhar, Rieke Alten, et al.. (2020). Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors. JCR Journal of Clinical Rheumatology. 27(8). e446–e455. 19 indexed citations
6.
Sullivan, E, et al.. (2020). Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan. Rheumatology and Therapy. 7(3). 517–535. 9 indexed citations
7.
Deodhar, Atul, Vibeke Strand, Philip G. Conaghan, et al.. (2020). Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study. BMC Rheumatology. 4(1). 19–19. 7 indexed citations
8.
Alten, Rieke, Philip G. Conaghan, Vibeke Strand, et al.. (2019). Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study. Clinical Rheumatology. 38(6). 1615–1626. 18 indexed citations
9.
Piercy, James, et al.. (2019). The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatology. 3(1). 43–43. 32 indexed citations
10.
Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2018). Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice. Patient Preference and Adherence. Volume 12. 2007–2014. 6 indexed citations
11.
Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2018). Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment. RMD Open. 4(1). e000615–e000615. 18 indexed citations
12.
Sullivan, E, James Piercy, John Waller, Christopher M. Black, & Sumesh Kachroo. (2017). Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany. PLoS ONE. 12(4). e0175826–e0175826. 39 indexed citations
13.
Scheinberg, Morton, Philip G. Conaghan, Rieke Alten, et al.. (2017). Psoriatic Arthritis Limits Patients’ Ability to Contribute to Society As Part of the Workforce: Results from A Multi-National Survey Including Latin America. Value in Health. 20(9). A903–A903. 1 indexed citations
14.
15.
Conaghan, Philip G., Vibeke Strand, E Sullivan, et al.. (2017). Appropriate Psoriatic Arthritis Treatment is Delayed for Years: Results From a Multi-National Survey Including Latin America. Value in Health. 20(9). A901–A901. 1 indexed citations
16.
Fürst, Daniel E., E Sullivan, James Pike, et al.. (2017). Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clinical Rheumatology. 36(9). 2045–2054. 29 indexed citations
17.
Waller, John, E Sullivan, James Piercy, Christopher M. Black, & Sumesh Kachroo. (2017). Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany. Patient Preference and Adherence. Volume 11. 519–530. 53 indexed citations
18.
19.
Sullivan, E, Richard Baker, Daryl Jones, et al.. (2007). Primary healthcare teams' views on using mortality data to review clinical policies. BMJ Quality & Safety. 16(5). 359–362. 4 indexed citations
20.
Baker, Richard, E Sullivan, Janette Camosso‐Stefinovic, et al.. (2007). Making use of mortality data to improve quality and safety in general practice: a review of current approaches. BMJ Quality & Safety. 16(2). 84–89. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.S. Mennini Breakdown of academic impact, for papers by Taru Hallinen Breakdown of academic impact, for papers by V. Chandran Breakdown of academic impact, for papers by Carole Desthieux Breakdown of academic impact, for papers by Jerry Syrotuik Breakdown of academic impact, for papers by Herman L. M. Brus Breakdown of academic impact, for papers by Brian Bekker Hansen Breakdown of academic impact, for papers by A. Clarke Breakdown of academic impact, for papers by Marios Kouloumas Breakdown of academic impact, for papers by Valgerður Sigurðardóttir
Rankless by CCL
2026